CN Stock MarketDetailed Quotes
600535 Tasly Pharmaceutical Group
- 15.07
- +0.43+2.94%
Market Closed Dec 12 15:00 CST
22.51BMarket Cap25.54P/E (TTM)
15.13High14.59Low229.20KlotVolume14.65Open14.64Pre Close342.67MTurnover1.53%Turnover Ratio21.02P/E (Static)1.49BShares17.4452wk High1.84P/B22.51BFloat Cap11.9152wk Low16.10Limit Up1.49BShs Float38.06Historical High13.18Limit Down3.69%Amplitude-3.05Historical Low0.66Dividend TTM14.95Avg Price87.57KlotAsk4.38%Div YieldTTM100Lot Size138.49KlotBid
Tasly Pharmaceutical Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -1.66%6.46B | -0.46%4.37B | -1.73%2.05B | 0.42%8.67B | 7.15%6.57B | 8.88%4.39B | 11.16%2.08B | 8.62%8.64B | 6.29%6.13B | 5.41%4.03B |
| Operating revenue | -1.66%6.46B | -0.46%4.37B | -1.73%2.05B | 0.42%8.67B | 7.15%6.57B | 8.88%4.39B | 11.16%2.08B | 8.62%8.64B | 6.29%6.13B | 5.41%4.03B |
| Other operating revenue | ---- | -36.37%21.84M | ---- | 20.90%37.71M | ---- | -17.22%34.32M | ---- | -42.09%31.19M | ---- | 10.87%41.46M |
| Total operating cost | -0.82%5.24B | -1.92%3.48B | -0.53%1.67B | -2.24%7.23B | 0.79%5.28B | 2.67%3.54B | 5.35%1.68B | 9.57%7.4B | 12.21%5.24B | 12.52%3.45B |
| Operating cost | -1.51%2.15B | -4.23%1.42B | -6.46%672.67M | -7.72%2.88B | 0.11%2.18B | 4.11%1.49B | 1.93%719.16M | 16.56%3.12B | 11.32%2.18B | 10.65%1.43B |
| Operating tax surcharges | -2.21%90.17M | -4.29%62.94M | 0.46%26.57M | -3.89%128.7M | 7.34%92.2M | 13.38%65.76M | 7.62%26.44M | 14.48%133.9M | 8.00%85.9M | 5.95%58M |
| Operating expense | -0.87%2.21B | -0.40%1.47B | 3.09%692.99M | 3.11%2.98B | 5.93%2.23B | 12.03%1.48B | 6.90%672.24M | -0.45%2.89B | 9.40%2.1B | 5.91%1.32B |
| Administration expense | 6.29%242.97M | -3.65%151.15M | -12.74%72.72M | -8.46%342.37M | -9.58%228.6M | -10.24%156.88M | 0.44%83.34M | -13.44%374.03M | -12.27%252.82M | -11.62%174.78M |
| Financial expense | -496.15%-11.74M | -118.58%-1.47M | -53.47%5.66M | -161.76%-19.06M | -105.94%-1.97M | -10.11%7.89M | -16.66%12.16M | -21.73%30.85M | 9.57%33.13M | -65.18%8.78M |
| -Interest expense (Financial expense) | -10.32%60.21M | 2.09%50.06M | -3.17%30.25M | 27.23%82.52M | 44.48%67.14M | 44.16%49.04M | 67.13%31.24M | -16.19%64.86M | -20.46%46.47M | -25.00%34.02M |
| -Interest Income (Financial expense) | 1.99%-72.6M | -21.73%-53.53M | -25.74%-26.72M | -164.55%-107.55M | -167.27%-74.08M | -131.32%-43.98M | -210.53%-21.25M | -18.61%-40.65M | -6.62%-27.72M | -9.61%-19.01M |
| Research and development | 1.15%564.77M | 5.32%370.37M | 20.43%199.38M | 8.51%917.27M | -5.53%558.32M | -24.47%351.67M | 20.70%165.57M | 45.87%845.34M | 49.02%591.04M | 81.66%465.62M |
| Credit Impairment Loss | 70.62%-1.43M | -5.09%-1.61M | -775.31%-2.88M | -711.20%-8.19M | -329.48%-4.86M | -456.59%-1.53M | -89.17%426.58K | -74.93%1.34M | 182.80%2.12M | -94.22%429.28K |
| Asset Impairment Loss | -1,492.35%-39.06M | -38.58%1.26M | 11.88%736.46K | 98.62%-5.12M | 1,993.42%2.81M | 5,286.46%2.05M | 275,771.45%658.28K | -39.21%-372.35M | ---148.16K | --38.12K |
| Other net revenue | -174.18%-221.61M | -423.69%-100.73M | 72.11%-5.38M | 84.76%-213.23M | 93.03%-80.82M | 97.93%-19.23M | 97.71%-19.3M | -191.26%-1.4B | -293.40%-1.16B | -320.46%-929.8M |
| Fair value change income | -88.84%-171.63M | -116.00%-87.73M | 86.96%-3.95M | 84.43%-171.88M | 92.62%-90.88M | 95.79%-40.61M | 96.51%-30.27M | -1,281.99%-1.1B | -521.95%-1.23B | -993.13%-965.4M |
| Invest income | -50.12%-52.23M | -198.31%-44M | -438.86%-12.4M | -414.71%-110.92M | -290.83%-34.79M | -152.88%-14.75M | 201.88%3.66M | -101.23%-21.55M | -91.54%18.23M | -102.57%-5.83M |
| -Including: Investment income associates | -12.50%-72.26M | -29.92%-51.3M | -111.69%-13.91M | -877.44%-130.04M | -1,429.89%-64.24M | -192.43%-39.49M | -110.07%-6.57M | 88.63%-13.3M | 108.45%4.83M | 62.63%-13.5M |
| Asset deal income | 231.72%185.9K | 24,424.95%257.73K | ---- | -90.13%146.34K | -114.78%-141.13K | -100.10%-1.06K | -99.94%750.89 | -96.65%1.48M | -97.88%954.97K | -97.74%1.02M |
| Other revenue | -9.56%42.55M | -12.69%31.09M | 110.61%13.11M | -13.75%82.75M | -5.28%47.05M | -10.87%35.61M | -72.25%6.23M | 31.75%95.94M | -0.97%49.67M | 18.05%39.95M |
| Operating profit | -17.10%1B | -4.07%795.64M | -3.42%373.28M | 867.03%1.23B | 547.53%1.21B | 338.90%829.42M | 168.92%386.48M | -105.86%-160.08M | -115.88%-269.58M | -129.39%-347.18M |
| Add:Non operating Income | 373.50%7.02M | 366.40%5.29M | 591.06%3.58M | 16.68%3.06M | 140.21%1.48M | 126.85%1.13M | 69.15%518.74K | -20.82%2.62M | -76.88%616.94K | -27.91%500.01K |
| Less:Non operating expense | 160.61%10.59M | 340.77%8.38M | 136.76%2.44M | -3.24%9.84M | -39.73%4.06M | -64.06%1.9M | 0.18%1.03M | -20.03%10.17M | -12.91%6.74M | 16.33%5.29M |
| Total profit | -17.22%996.57M | -4.36%792.55M | -2.99%374.42M | 828.44%1.22B | 536.65%1.2B | 335.43%828.65M | 168.74%385.97M | -106.15%-167.63M | -116.29%-275.71M | -129.90%-351.97M |
| Less:Income tax cost | -17.35%168.43M | -1.63%139.54M | -34.78%81.41M | 13.07%204.46M | 41.41%203.77M | 17.92%141.84M | 264.32%124.81M | -42.76%180.82M | -30.39%144.1M | -23.16%120.28M |
| Net profit | -17.19%828.14M | -4.92%653.01M | 12.20%293.01M | 391.76%1.02B | 338.23%1B | 245.43%686.81M | 143.84%261.16M | -114.47%-348.46M | -128.26%-419.81M | -146.27%-472.26M |
| Net profit from continuing operation | -17.19%828.14M | -4.92%653.01M | 12.20%293.01M | 391.76%1.02B | 338.23%1B | 245.43%686.81M | 143.84%261.16M | -114.47%-348.46M | -128.26%-419.81M | -146.27%-472.26M |
| Less:Minority Profit | 56.23%-14.06M | 54.17%-9.3M | 35.84%-2.2M | 35.37%-54.43M | 57.58%-32.11M | 63.58%-20.29M | 91.00%-3.43M | -272.75%-84.22M | -1,764.14%-75.71M | -400.09%-55.7M |
| Net profit of parent company owners | -18.41%842.2M | -6.33%662.31M | 11.58%295.21M | 505.34%1.07B | 399.97%1.03B | 269.75%707.09M | 147.44%264.59M | -111.20%-264.24M | -123.23%-344.1M | -141.57%-416.55M |
| Earning per share | ||||||||||
| Basic earning per share | -18.84%0.56 | -6.38%0.44 | 11.11%0.2 | 500.00%0.72 | 400.00%0.69 | 268.88%0.47 | 148.40%0.18 | -111.46%-0.18 | -123.23%-0.23 | -141.72%-0.2783 |
| Diluted earning per share | -18.84%0.56 | -6.38%0.44 | 11.11%0.2 | 500.00%0.72 | 400.00%0.69 | 268.88%0.47 | 148.40%0.18 | -111.46%-0.18 | -123.23%-0.23 | -141.72%-0.2783 |
| Other composite income | 80.92%-17.46M | 83.79%-12.07M | 95.76%-4.84M | -149.69%-123.45M | -172.46%-91.52M | -663.29%-74.46M | -12,453.24%-114.24M | 3,473.16%248.44M | 2,212.48%126.31M | 621.24%13.22M |
| Other composite income of parent company owners | 80.78%-17.66M | 83.56%-12.35M | 95.50%-5.16M | -150.63%-123.58M | -176.75%-91.87M | -669.18%-75.13M | -12,505.54%-114.72M | 3,541.66%244.1M | 2,101.93%119.7M | 620.50%13.2M |
| Other composite income of minority owners | -44.11%194.44K | -57.63%284.63K | -33.73%315.38K | -96.93%133.05K | -94.74%347.93K | 3,485.71%671.81K | --475.9K | 1,691.16%4.34M | --6.61M | --18.74K |
| Total composite income | -10.78%810.68M | 4.67%640.94M | 96.15%288.17M | 993.04%893.19M | 409.56%908.58M | 233.40%612.35M | 124.62%146.92M | -104.17%-100.02M | -119.84%-293.5M | -145.08%-459.04M |
| Total composite income of parent company owners | -12.32%824.54M | 2.85%649.96M | 93.54%290.05M | 4,804.83%947.49M | 519.04%940.35M | 256.68%631.96M | 126.83%149.87M | -100.86%-20.14M | -115.21%-224.41M | -140.35%-403.35M |
| Total composite income of minority owners | 56.36%-13.86M | 54.05%-9.01M | 36.19%-1.88M | 32.02%-54.3M | 54.03%-31.77M | 64.78%-19.61M | 92.25%-2.95M | -264.77%-79.88M | -1,618.84%-69.1M | -399.99%-55.68M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
